$PCTL announces that PCTL and RB Capital Partners, Inc. have executed and received an additional $150,000 conventional, convertible loan with 5% annual interest and a $0.10/share fixed conversion rate. PCTL has earmarked a large portion of these monies for the build and completion of 4 Annihilyzer® Infection Control Systems for the Healthcare Industry and the completion of 3 pieces of the Company’s Legacy equipment.
With regard to the Company’s issued and outstanding shares; as of today, our I/O share count has remained the same at 721,187,846 shares.
As PCTL continues its pursuit to gain acceptance to list on OTC:QB, we are in the final stages of addressing all comments from the OTC Markets Compliance Team. Provided there are no more questions, the process will proceed in queue with OTC Markets for the jump to the OTC:QB listing.